Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Corneal melting after use of nepafenac in a patient with chronic cystoid macular edema after cataract surgery.

Di Pascuale MA, Whitson JT, Mootha VV.

Eye Contact Lens. 2008 Mar;34(2):129-30. doi: 10.1097/ICL.0b013e31814510a8.

PMID:
18327052
[PubMed - indexed for MEDLINE]
2.

Nepafenac-associated corneal melt.

Wolf EJ, Kleiman LZ, Schrier A.

J Cataract Refract Surg. 2007 Nov;33(11):1974-5.

PMID:
17964407
[PubMed - indexed for MEDLINE]
3.

Case of corneal melting associated with the use of topical nepafenac.

Bekendam PD, Narváez J, Agarwal M.

Cornea. 2007 Sep;26(8):1002-3.

PMID:
17721306
[PubMed - indexed for MEDLINE]
4.

Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery.

Miyake K, Ota I, Miyake G, Numaga J.

J Cataract Refract Surg. 2011 Sep;37(9):1581-8. doi: 10.1016/j.jcrs.2011.03.052.

PMID:
21855758
[PubMed - indexed for MEDLINE]
5.

NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.

Warren KA, Bahrani H, Fox JE.

Retina. 2010 Feb;30(2):260-6.

PMID:
20175270
[PubMed - indexed for MEDLINE]
6.

Topical nepafenac as an alternate treatment for cystoid macular edema in steroid responsive patients.

Warren KA, Fox JE.

Retina. 2008 Nov-Dec;28(10):1427-34. doi: 10.1097/IAE.0b013e31817e7ead.

PMID:
18664937
[PubMed - indexed for MEDLINE]
7.

Cystoid and diabetic macular edema treated with nepafenac 0.1%.

Hariprasad SM, Callanan D, Gainey S, He YG, Warren K.

J Ocul Pharmacol Ther. 2007 Dec;23(6):585-90.

PMID:
18001248
[PubMed - indexed for MEDLINE]
8.

Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac.

Wolf EJ, Braunstein A, Shih C, Braunstein RE.

J Cataract Refract Surg. 2007 Sep;33(9):1546-9.

PMID:
17720068
[PubMed - indexed for MEDLINE]
9.

Nepafenac-associated bilateral corneal melt after photorefractive keratectomy.

Feiz V, Oberg TJ, Kurz CJ, Mamalis N, Moshirfar M.

Cornea. 2009 Sep;28(8):948-50. doi: 10.1097/ICO.0b013e318199e9cc.

PMID:
19654513
[PubMed - indexed for MEDLINE]
10.

Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema.

Mathys KC, Cohen KL.

Eye (Lond). 2010 Jan;24(1):90-6. doi: 10.1038/eye.2009.10. Epub 2009 Feb 20.

PMID:
19229275
[PubMed - indexed for MEDLINE]
11.

Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.

Duong HV, Westfield KC, Chalkley TH.

J Cataract Refract Surg. 2007 Nov;33(11):1925-9.

PMID:
17964399
[PubMed - indexed for MEDLINE]
12.

Possible role of the vitamin E solubilizer in topical diclofenac on matrix metalloproteinase expression in corneal melting: an analysis of postoperative keratolysis.

Hargrave SL, Jung JC, Fini ME, Gelender H, Cather C, Guidera A, Udell I, Fisher S, Jester JV, Bowman RW, McCulley JP, Cavanagh HD.

Ophthalmology. 2002 Feb;109(2):343-50.

PMID:
11825822
[PubMed - indexed for MEDLINE]
13.

Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification.

Almeida DR, Khan Z, Xing L, Bakar SN, Rahim K, Urton T, El-Defrawy SR.

J Cataract Refract Surg. 2012 Sep;38(9):1537-43. doi: 10.1016/j.jcrs.2012.04.034. Epub 2012 Jul 15.

PMID:
22795976
[PubMed - indexed for MEDLINE]
14.

Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac.

Lindstrom R, Kim T.

Curr Med Res Opin. 2006 Feb;22(2):397-404. Review. Erratum in: Curr Med Res Opin. 2006 Jun;22(6):1237.

PMID:
16466612
[PubMed - indexed for MEDLINE]
15.
16.

Resolution of pseudophakic cystoid macular edema with combination therapy of topical corticosteroids and nonsteroidal anti-inflammatory drugs.

Romac I, Gabrić N, Dekaris I, Barisić A.

Coll Antropol. 2011 Sep;35 Suppl 2:281-4.

PMID:
22220453
[PubMed - indexed for MEDLINE]
17.

Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs.

Flach AJ.

Trans Am Ophthalmol Soc. 2001;99:205-10; discussion 210-2.

PMID:
11797308
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies.

Soheilian M, Karimi S, Ramezani A, Peyman GA.

Retina. 2010 Mar;30(3):509-15. doi: 10.1097/IAE.0b013e3181bdfa43.

PMID:
19952986
[PubMed - indexed for MEDLINE]
19.

Role of topical nepafenac in prevention and treatment of macular edema after vitreoretinal surgery.

Naithani P, Puranik S, Vashisht N, Khanduja S, Kumar S, Garg S.

Retina. 2012 Feb;32(2):250-5. doi: 10.1097/IAE.0b013e31821e2057.

PMID:
21926942
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk